INTRODUCTION {#s1}
============

Activation of monocytes and differentiation into macrophages are major steps in vascular proliferative diseases like atherosclerosis and restenosis \[[@R1]-[@R3]\]. Monocytes/macrophages produce growth factors that stimulate vascular smooth muscle cell (VSMC) differentiation and growth \[[@R4], [@R5]\], while contributing to the deposition of extracellular matrix (ECM) to facilitate immune cell infiltration \[[@R6], [@R7]\] and myofibroblastic migration from the adventitia \[[@R8]\]. It is believed that aged-related changes in monocyte numbers and phenotypes contribute to the development of vascular diseases in the elderly \[[@R9]-[@R12]\].

Most recently, we and others demonstrated that aging exacerbates neointimal hyperplasia (NIH) after vascular injury, likely as a consequence of increased infiltration of monocytes \[[@R6], [@R13]\] and higher sensitivity of VSMC to proliferation stimuli \[[@R8]\]. Interestingly, we also found that monocytes/macrophages in aged rats are more pro-inflammatory and adhesive than in younger animals, which in part explains the increased number of macrophages after vascular injury in aged vasculature \[[@R6]\]. Not surprisingly, pharmacological depletion of monocytes compromises neointima development after arterial injury \[[@R6]\].

This study aims at demonstrating the restenotic properties of aged monocytes in the rat model of vascular injury. We controled for additional age-related interacting factors and demonstrate for the first time that changes in monocytes from aged rats are sufficient to exacerbate NIH after arterial injury. Gene expression profiles of monocytes from young and aged rats revealed significant differences in the expression of adhesion molecules, cytotoxic factors, as well as genes associated with inflammation, cellular differentiation and migration. Altogether, our work identifies potential molecular players that may be involved in the differential contribution of monocytes to post-injury restenosis with aging.

RESULTS {#s2}
=======

Aged rats have higher counts of blood monocytes than younger animals {#s2_1}
--------------------------------------------------------------------

In order to investigate possible age-related changes in monocytes that may explain a differential contribution to NIH after vascular injury, monocytic cells from Fischer rats aged 2 and 22 months old (*n* = 3 per age group) were isolated and purified by negative immunomagnetic separation. Purified live cells were 90% monocytes, of which over 75% stained positive for both CD11b/c and CD18 (Figure [1A](#F1){ref-type="fig"}). The isolated monocytes were essentially negative for the CD4 and CD8 markers (Figure [1A](#F1){ref-type="fig"}). The total percentage of monocytes in peripheral blood mononuclear cells (PBMC) was significantly higher in aged rats compared to young animals (14.4 ± 2.0 *vs*. 6.6 ± 0.2%, *p* = 0.02; Figure [1B](#F1){ref-type="fig"}), as previously reported \[[@R13]\], while the opposite was observed for peripheral lymphocytes, although not statistically significant (43.1 ± 12.3 *vs*. 49.4 ± 21.2%, *p* = 0.8).

![Aging causes monocytosis in rats\
**A.** Representative flow cytometry analysis of purified monocytes. **B.**Cell counts ± SEM of monocytes, granulocytes and lymphocytes in young and aged rats (*n* = 3 per group). Numbers are expressed as percentages of peripheral blood mononuclear cells. \**p* \< 0.05.](oncotarget-06-17054-g001){#F1}

Monocytes from aged rats exacerbate NIH in injured arteries of young animals {#s2_2}
----------------------------------------------------------------------------

Age-related phenotypic differences in human monocytes have been associated with an increased risk for atherosclerosis and restenosis \[[@R12], [@R14], [@R15]\]. We investigated whether, in the absence of confounding age-related factors, monocytes from aged rats were sufficient to exacerbate NIH in injured arteries of young animals. To this end, approximately 2×10^6^ monocytes isolated from young and aged animals were delivered perivascularly around injured arteries of young recipients (*n* = 6 per age group). A control group received an equivalent volume of vehicle under the same conditions (*n* = 6).

Arteries that received monocytes from aged animals developed thicker neointimas than those that received cells from young rats (N/M ratio: 0.63 ± 0.09 *vs*. 0.40 ± 0.05, *p* = 0.049; Figure [2](#F2){ref-type="fig"}). In contrast, monocytes from young animals did not modify neointima thickness with respect to rats receiving vehicle alone (N/M ratio: 0.37 ± 0.05, *p* = 0.7). The number of CD68^+^ macrophages increased significantly in the adventitia of arteries that received monocytes compared to the vehicle control (24.50 ± 5.07 in control *vs*. 47.25 ± 6.29 cells per section in aged, *p* = 0.03; Figure [3A-3B](#F3){ref-type="fig"}). However, despite the differences observed in neointima thickness measurements between arteries that received cells from young or aged donors, no significant differences in the number of infiltrated macrophages were detected between both experimental conditions (52.00 ± 5.20 *vs*. 47.25 ± 6.29 cells per section, *p* = 0.6; Figure [3B](#F3){ref-type="fig"}).

![Monocytes from aged rats exacerbate post-injury neointimal hyperplasia in young arteries\
**A**-**B.** Equal numbers of monocytes from young and aged rats were suspended in Matrigel and exogenously seeded around arteries prior to balloon injury. **A**. Hematoxylin and Eosin and **B.** SMA stained cross-sections of injured arteries treated with Matrigel alone, or monocytes from young and aged donors, and harvested 21 days after injury. The neointima layer is delineated by arrows. **C.** Neointima-to-media ratios of the three experimental groups expressed as mean ratio ± SEM (*n* = 6 per group). \**p* \< 0.05.](oncotarget-06-17054-g002){#F2}

![Perivascular delivery of monocytes from young and aged rats increased the number of CD68+ macrophages in the adventitia\
**A.** Immunofluorescent staining of injured arteries 21 days after surgery using an anti-CD68 antibody. CD68^+^ macrophages are shown in yellow, while nuclei were counter-stained with DAPI (blue). **B.** Number of macrophages per section in the three experimental groups. Bars represent the mean ± SEM (*n* = 4 per group). \**p* \< 0.05.](oncotarget-06-17054-g003){#F3}

Adhesion molecules and pro-inflammatory factors are differentially expressed in monocytes from aged and young animals {#s2_3}
---------------------------------------------------------------------------------------------------------------------

We then looked for differentially expressed genes that could account for the increased restenotic effect of monocytes from aged animals. Table [1](#T1){ref-type="table"} lists significantly up-regulated genes in monocytes from aged rats compared to those from young donors (*n* = 3 per group). Interestingly, this list includes a number of transcripts involved in differentiation (*Csf1, Egr1, Gfi1, Gprc5a, Jun, Rasl11b*), cell survival (*Dapk2, Nol3*), migration (*Lpar3*), cell adhesion (*Asam, Cd24, Cdh13, Chn2, Cldn23, Esam, Mcam, Mpp7*), cytotoxicity (*Gzmbl3, Gzmf*), ECM remodeling (*Cela1*), and inflammation (*Cxcl1, Dusp2, Ifng, Klrb1, Lyzl4, Nr4a2, Nr4a3, Plk2, Plk3, Rgs16*). Numerous genes coding for cytoskeletal proteins (*Actn2, Anxa8, Calb2, Dnah8, Gels, Mark1, Myh2, Scin, Tnni1*), cell cycle modulators (*Btg3, Cdkn2a, Cenpt, Cks1b, Cks2, Gmnn, Kif20b, Plk3, Prc1, Spag5, Spc25*), as well as lipid degradation enzymes (*Pla2g2f, Pnliprp2*) were also up-regulated.

###### Significantly up-regulated genes in monocytes from aged vs. young rats

  Gene       Description                                                  Fold change   p          FDR
  ---------- ------------------------------------------------------------ ------------- ---------- ----------
  Pnliprp2   Pancreatic lipase-related protein 2                          372.49        0.00E+00   1.00E-05
  Ispd       Isoprenoid synthase domain-containing protein                366.83        0.00E+00   1.13E-03
  Anxa8      Annexin A8                                                   210.29        0.00E+00   1.70E-04
  Gzmf       Granzyme F                                                   208.57        0.00E+00   3.24E-03
  Sfrp1      Secreted frizzled-related protein 1                          195.25        1.00E-05   3.24E-03
  Cdh13      Cadherin 13                                                  61.88         0.00E+00   3.10E-04
  Lama3      Laminin alpha 3                                              57.29         3.00E-05   5.99E-03
  Calb2      Calbindin 2                                                  52.87         5.00E-05   7.68E-03
  Thumpd1    THUMP domain-containing protein 1                            40.75         0.00E+00   1.00E-05
  Klrb1      Killer cell lectin-like receptor subfamily B member 1        40.66         3.00E-05   6.22E-03
  Ppic       Peptidyl-prolyl cis-trans isomerase C                        34.04         1.80E-04   1.73E-02
  Asam       Adipocyte adhesion molecule                                  24.46         1.00E-05   3.24E-03
  Lyzl4      Lysozyme A                                                   22.60         9.00E-05   1.10E-02
  Cdkn2a     Cyclin-dependent kinase inhibitor 2A                         21.33         2.00E-05   5.55E-03
  Cela1      Chymotrypsin-like elastase family member 1                   15.50         6.00E-05   8.58E-03
  Lrrc72     Leucine-rich repeat-containing protein 72                    12.78         1.00E-05   3.24E-03
  Tnni1      Troponin I, slow skeletal muscle                             12.60         4.80E-04   3.50E-02
  Resp18     Regulated endocrine-specific protein 18                      12.48         3.00E-04   2.63E-02
  Nr4a3      Nuclear receptor subfamily 4 group A member 3                12.13         1.00E-05   4.56E-03
  Dnah8      Dynein, axonemal heavy chain 8                               11.74         1.30E-04   1.45E-02
  Ephb3      Ephrin type-B receptor 3                                     11.41         2.00E-05   5.55E-03
  Atp1a2     Sodium/potassium-transporting ATPase subunit alpha-2         10.16         2.00E-05   5.55E-03
  Mcam       Cell surface glycoprotein MUC18                              9.85          2.00E-05   5.35E-03
  Mpp7       MAGUK p55 subfamily member 7                                 8.67          3.00E-05   6.33E-03
  Actn2      Actinin alpha 2                                              8.53          7.80E-04   4.89E-02
  Slc4a4     Electrogenic sodium bicarbonate cotransporter 1              8.42          1.00E-05   3.24E-03
  Dusp2      Dual specificity protein phosphatase 2                       8.19          3.00E-05   6.33E-03
  Ifng       Interferon gamma                                             6.45          2.00E-05   5.43E-03
  Spag5      Sperm associated antigen 5                                   5.99          7.00E-04   4.52E-02
  Pask       PAS domain-containing serine/threonine protein kinase        5.93          7.00E-04   4.87E-02
  Cldn23     Claudin 23                                                   5.86          7.00E-05   9.12E-03
  Gstt3      Glutathione S-transferase theta 3                            5.75          5.40E-04   3.79E-02
  Gfi1       Zinc finger protein Gfi-1                                    5.73          4.00E-05   6.77E-03
  Lpar3      Lysophosphatidic acid receptor 3                             5.65          1.00E-04   1.18E-02
  Nol3       Nucleolar protein 3                                          5.62          1.30E-04   1.43E-02
  Gzmbl3     Granzyme B-like 3                                            5.56          0.00E+00   2.46E-03
  Copz2      Coatomer protein complex, subunit zeta 2                     5.14          3.20E-04   2.68E-02
  Kif20b     M-phase phosphoprotein 1                                     5.04          6.20E-04   4.15E-02
  Nr4a2      Nuclear receptor subfamily 4 group A member 2                5.00          5.00E-05   7.84E-03
  Myh2       Myosin, heavy chain 2                                        4.95          4.50E-04   3.35E-02
  Cks1b      Cyclin-dependent kinases regulatory subunit 1                4.83          4.10E-04   3.16E-02
  Spc25      Kinetochore protein Spc25                                    4.72          6.30E-04   4.22E-02
  Arhgef39   Rho guanine nucleotide exchange factor 39                    4.51          4.00E-04   3.13E-02
  Gfra2      GDNF family receptor alpha-2                                 4.47          5.20E-04   3.71E-02
  Plk3       Serine/threonine-protein kinase PLK3                         4.47          2.00E-05   5.36E-03
  Plk2       Serine/threonine-protein kinase PLK2                         4.43          2.00E-05   5.35E-03
  Dapk2      Death-associated kinase 2                                    4.35          3.40E-04   2.78E-02
  Agpat3     1-acyl-sn-glycerol-3-phosphate acyltransferase gamma         4.34          2.20E-04   2.00E-02
  Tmem246    Transmembrane protein 246                                    4.33          1.00E-05   4.56E-03
  Scin       Adseverin                                                    4.32          1.70E-04   1.69E-02
  Esam       Endothelial cell-selective adhesion molecule                 4.21          3.60E-04   2.93E-02
  Cks2       Cyclin-dependent kinases regulatory subunit 2                4.18          8.00E-05   1.07E-02
  Sgca       Alpha sarcoglycan                                            4.18          3.10E-04   2.66E-02
  Rasl11b    Ras-like protein family member 11B                           4.15          7.00E-05   9.12E-03
  Csf1       Macrophage colony-stimulating factor 1                       4.11          4.50E-04   3.35E-02
  Fv1        Friend virus susceptibility protein 1                        4.07          4.70E-04   3.46E-02
  Chn2       Beta-chimaerin                                               4.01          4.40E-04   3.34E-02
  Ube2t      Ubiquitin-conjugating enzyme E2T                             3.95          5.10E-04   3.76E-02
  Xxylt1     Xyloside xylosyltransferase 1                                3.95          6.00E-05   8.91E-03
  Srpk3      Serine/arginine-rich splicing factor protein kinase 3        3.90          4.00E-05   6.56E-03
  Prc1       Protein regulator of cytokinesis 1                           3.82          7.40E-04   4.72E-02
  Cxcl1      Chemokine (C-X-C motif) ligand 1                             3.76          7.60E-04   4.81E-02
  Mfsd4      Major facilitator superfamily domain-containing protein 4    3.74          7.00E-05   9.23E-03
  Cd24       Signal transducer CD24                                       3.68          5.80E-04   3.98E-02
  Gprc5a     Retinoic acid-induced protein 3                              3.63          3.40E-04   2.80E-02
  Mark1      Serine/threonine-protein kinase MARK1                        3.61          1.00E-04   1.22E-02
  Rgs16      Regulator of G-protein signaling 16                          3.61          1.00E-04   1.18E-02
  Gmnn       Geminin                                                      3.54          2.00E-04   1.90E-02
  Chrne      Acetylcholine receptor subunit epsilon                       3.45          1.90E-04   1.80E-02
  Calcr      Calcitonin receptor                                          3.41          7.30E-04   4.66E-02
  Sccpdh     Saccharopine dehydrogenase-like oxidoreductase               3.37          4.00E-04   3.14E-02
  Pik3r1     Phosphoinositide-3-kinase, regulatory subunit 1 alpha        3.36          5.30E-04   3.77E-02
  Ly49i4     Ly49 inhibitory receptor 4                                   3.35          4.50E-04   3.35E-02
  Slco4a1    Solute carrier organic anion transporter family member 4A1   3.23          1.30E-04   1.43E-02
  Ppp1r36    Protein phosphatase 1, regulatory subunit 36                 3.04          7.00E-04   4.52E-02
  Pla2g2f    Group IIF secretory phospholipase A2                         3.03          3.20E-04   2.70E-02
  Syne1      Spectrin repeat-containing, nuclear envelope protein 1       2.97          6.60E-04   4.34E-02
  Egr1       Early growth response protein 1                              2.95          7.00E-04   4.52E-02
  Gels       Gelsolin                                                     2.92          1.30E-04   1.43E-02
  Wdr25      WD repeat-containing protein 25                              2.90          1.80E-04   1.73E-02
  Prdm1      PR domain zinc finger protein 1                              2.82          4.80E-04   3.50E-02
  Jun        Transcription factor AP-1                                    2.73          1.40E-04   1.51E-02
  Grk4       G protein-coupled receptor kinase 4                          2.42          6.20E-04   4.15E-02
  Lmnb1      Lamin B1                                                     2.39          6.20E-04   4.15E-02
  Btg3       Protein BTG3                                                 2.19          7.30E-04   4.66E-02

On the other hand, the group of down-regulated genes (or up-regulated in monocytes from young rats compared to aged animals) included transcripts involved in immune regulation (*Tnfrsf17*), chemotaxis (*CCr10, S1pr1*), TLR signaling (*Ticam1*), and antigen presentation (*RT1*; Table [2](#T2){ref-type="table"}). Numerous B cell and red blood cell (RBC) related transcripts are also up-regulated in monocytes from young rats. While the latter may be suggestive of contamination with other cell types, other studies have reported similar findings in the past, including the expression of IgM proteins \[[@R16]\].

###### Significantly down-regulated genes in monocytes from aged vs. young rats

  Gene       Description                                                       Fold change   p          FDR
  ---------- ----------------------------------------------------------------- ------------- ---------- ----------
  S1pr1      Sphingosine 1-phosphate receptor 1                                0.03          3.20E-04   2.68E-02
  Hbe1       Hemoglobin, epsilon 1                                             0.04          7.40E-04   4.72E-02
  Slc4a1     Solute carrier organic anion transporter family member 4A1        0.05          1.70E-04   1.69E-02
  Eraf       Alpha hemoglobin stabilizing protein                              0.08          5.50E-04   3.83E-02
  IGKV       Immunoglobulin kappa light chain V region                         0.08          4.00E-05   6.79E-03
  IGG2A      Immunoglobulin gamma-2A chain C region                            0.10          1.20E-04   1.38E-02
  Ccr10      C-C chemokine receptor type 10                                    0.11          3.00E-05   6.05E-03
  Zcchc14    Zinc finger, CCHC domain-containing protein 14                    0.12          4.00E-05   6.53E-03
  Mzb1       Marginal zone B and B1 cell-specific protein                      0.14          2.00E-05   5.35E-03
  Tnfrsf17   Tumor necrosis factor receptor superfamily member 17              0.14          1.00E-05   3.24E-03
  IGLC2      Immunoglobulin lambda-2 chain C region                            0.16          3.00E-05   6.19E-03
  Cd79b      B-cell antigen receptor complex-associated protein, beta chain    0.17          1.00E-05   4.64E-03
  Pxdc1      PX domain-containing protein 1                                    0.17          5.00E-05   7.84E-03
  Vpreb3     Pre-B lymphocyte protein 3                                        0.17          3.00E-05   5.99E-03
  Olr686     Olfactory receptor Olr686                                         0.19          1.30E-04   1.43E-02
  Itih4      Inter-alpha-trypsin inhibitor heavy chain family, member 4        0.20          8.00E-05   1.01E-02
  Slc22a23   Solute carrier family 22 member 23                                0.20          2.00E-05   5.55E-03
  Derl3      Derlin-3                                                          0.23          1.00E-05   4.56E-03
  Rhbdl1     Rhomboid, veinlet-like protein 1                                  0.23          3.00E-05   6.33E-03
  Ms4a1      Membrane-spanning 4-domains, subfamily A, member 1                0.23          1.40E-04   1.46E-02
  Cd79a      B-cell antigen receptor complex-associated protein, alpha chain   0.23          1.00E-04   1.20E-02
  Eaf2       ELL-associated factor 2                                           0.24          1.80E-04   1.75E-02
  Sspn       Sarcospan                                                         0.24          4.90E-04   3.55E-02
  Pde6h      Cone-like cGMP-phosphodiesterase 6 gamma subunit                  0.24          2.90E-04   2.58E-02
  Try10      Trypsin 10 precursor                                              0.25          2.10E-04   1.92E-02
  Fcer2      IgE Fc receptor, low affinity II, alpha polypeptide isoform b     0.26          1.70E-04   1.72E-02
  RT1-CE10   RT1 class I, locus CE10                                           0.28          8.00E-05   1.07E-02
  Myf6       Myogenic factor 6                                                 0.30          1.70E-04   1.72E-02
  Gas6       Growth arrest-specific protein 6                                  0.30          1.40E-04   1.47E-02
  Jakmip1    Janus kinase and microtubule-interacting protein 1                0.31          9.00E-05   1.13E-02
  Pon1       Serum paraoxonase/arylesterase 1                                  0.32          6.90E-04   4.50E-02
  Dgkg       Diacylglycerol kinase, theta                                      0.32          4.50E-04   3.35E-02
  Txndc5     Thioredoxin domain-containing protein 5, endoplasmic reticulum    0.33          4.00E-05   6.49E-03
  RT1-CE3    RT1 class I, locus CE3                                            0.33          1.80E-04   1.75E-02
  RT1-A2     RT1 class I, locus A2                                             0.33          3.90E-04   3.09E-02
  Idh1       Isocitrate dehydrogenase \[NADP\], cytoplasmic                    0.35          5.80E-04   3.98E-02
  Ticam1     Toll-like receptor adaptor molecule 1                             0.36          3.90E-04   3.09E-02
  Hvcn1      Hydrogen voltage-gated channel 1                                  0.37          3.60E-04   2.95E-02
  Sec11c     Signal peptidase complex catalytic subunit SEC11C                 0.37          6.00E-05   8.26E-03
  Musk       Muscle, skeletal, receptor tyrosine protein kinase                0.38          6.40E-04   4.26E-02
  Dgka       Diacylglycerol kinase, alpha                                      0.39          5.90E-04   4.02E-02
  Nol4l      Nucleolar protein 4-like                                          0.42          6.80E-04   4.45E-02
  Mkrn1      Makorin ring finger protein 1                                     0.43          4.10E-04   3.20E-02
  Pdia4      Protein disulfide isomerase-associated 4                          0.43          4.30E-04   3.31E-02

The mRNA and protein expressions of two of the most up-regulated transcripts (*Cdh13* and *Sfrp1*) were confirmed by qRT-PCR and immunofluorescence (Figure [4](#F4){ref-type="fig"}). Both analyses demonstrate higher expressions of both genes in monocytes from aged rats compared to young animals. Nevertheless, the immunofluorescence staining clearly shows that monocytes isolated from animals of both age groups are heterogeneous in nature, since not all cells stained uniformly for SFRP1 and different levels of fluorescence are evident for CADH13 (Figure [4B](#F4){ref-type="fig"}).

![Aging induces significant gene expression differences in rat monocytes\
**A.** Confirmatory qRT-PCR for cadherin 13 (*Cdh13)* and secreted frizzled-related protein 1 (*Sfrp1)* in monocytes. Gene expression (GE) is expressed in fold change of aged *vs*. young as calculated using the ddCT method. **B.** Immunofluorescent staining of young and aged monocytes using antibodies against CDH13 and SFRP1.](oncotarget-06-17054-g004){#F4}

DISCUSSION {#s3}
==========

Numerous studies indicate that aging favors pro-inflammatory phenotypes on monocytes, which predispose for cardiovascular disease and chronic subclinical inflammation \[[@R9]-[@R12]\]. In this work we demonstrated that 1) aging causes monocytosis in rats, 2) monocytes from aged animals exacerbate NIH, and 3) aging induces profound differences in monocyte gene expression.

Our results underscore the pro-inflammatory potential of monocytes from aged animals in the vascular response to balloon injury. Perivascular delivery of equal numbers of monocytes from either young or aged donors to young injured arteries showed that cells from aged rats have restenotic properties, in contrast to those from young animals. In addition, the different effects of monocytes from both age groups on neointima development occurred in the absence of other age-related aggravating factors, including monocytosis. In agreement with previous reports \[[@R13]\], we confirmed that a higher percentage of monocytes in PBMC is associated with aging in rats. But more importantly, we showed that, although higher cell counts may contribute to NIH, it is the phenotypic changes in monocytes from aged rats that are truly responsible for inducing constrictive vascular remodeling. The number of infiltrated macrophages in injured arteries was the same at 21 days with monocytes from both groups. This suggests that the different effects on neointima formation were mostly caused by secretable factors and/or that detectable differences in macrophage infiltration occurred at an earlier time point after the procedure. It is also likely that other age-related factors in the vascular wall further stimulate infiltration, differentiation and macrophage survival in injured arteries, as previously demonstrated by our group \[[@R6]\].

The gene expression profile of monocytes from aged rats reveals possible mediators of their restenotic and pro-inflammatory properties. In addition to the numerous up-regulated adhesion molecules (Table [1](#T1){ref-type="table"} and Results), monocytes from aged animals have higher expression of *Csf1, Cxcl1,* and *Ifng*. This combination of cytokines is highly synergistic. As the primary growth factor for the differentiation of monocytes into macrophages, CSF1 is more potent in combination with IFNγ \[[@R17]\]. The latter is a major inflammatory cytokine and contributes to the development of NIH after balloon angioplasty by inducing VSMC proliferation \[[@R5]\]. CXCL1, in turn, amplifies the inflammatory response and stimulates the recruitment of additional monocytes \[[@R7]\]. As an antagonist of the Wnt/β-catenin pathway, SFRP1 is expected to reduce chemotaxis and decrease VSMC proliferation \[[@R18]\]. However, overexpression of this protein is also known to improve cell-to-cell contacts with endothelial cells (EC) and VSMC \[[@R19]\], and it may influence ECM remodeling by up-regulating metalloproteinases \[[@R20]\]. Other up-regulated genes such as *Dusp2, Egr1, Lpar3*, *Plk3,* and *Rasl11b* are also stimulators of monocyte differentiation and inflammatory responses \[[@R21]-[@R25]\].

Monocytes from aged rats also demonstrate up-regulated gene expression of the secretable cytotoxic factors GZMBL3, GZMF, and LYZL4. Granzymes are normally not regarded as monocyte-derived. However, several groups have shown that granzyme B is also produced by monocytes \[[@R26], [@R27]\]. Vascular research has been limited to this enzyme, which was found in the intima and media of advanced atherosclerotic lesions \[[@R28]\]. In addition, a recent work demonstrated that granzyme B increased vascular permeability by releasing vascular endothelial growth factor (VEFG) from the ECM \[[@R29]\]. In the setting of restenosis, it is possible that granzymes contribute to excessive VSMC cytotoxicity, which compromises the healing response of the wall and exacerbates inflammation \[[@R30]\]. Similarly, lysozyme M-positive monocytes are known to amplify oxidative stress in the vascular wall \[[@R31]\], suggesting that other lysozymes may also increase inflammation.

In contrast to the high number of adhesion molecules, chemotactic factors and inflammatory mediators overexpressed in monocytes from aged rats, up-regulated genes in cells isolated from young rats do not suggest a pro-inflammatory profile (Table [2](#T2){ref-type="table"} and Results). Instead, up-regulation of MHC class I receptor genes (*RT1*) and *S1p1r* indicate increased involvement in antigen presentation processes and trafficking to and from lymphoid organs \[[@R32]\]. Likewise, monocytes from young rats demonstrate up-regulated expression of the TLR3 and TLR4 intracellular adaptor TICAM-1, which likely relates to the increased response to bacterial LPS that is normally observed in young individuals \[[@R11]\].

Of note, a number of similarities in gene expression can be observed between monocytes from aged rats and pro-inflammatory CD16^+^ subpopulations in humans. These include up-regulation of granzymes, *Dusp2, Egr1, Gfra2*, and *Klrb1* \[[@R26], [@R33], [@R34]\]. Interestingly, higher numbers of these subpopulations are found in the elderly and in individuals with chronic inflammatory conditions \[[@R9], [@R12]\], where they have been associated with atherosclerosis and restenosis \[[@R12], [@R14], [@R15]\]. In addition, multiple pro-atherogenic factors are overexpressed in monocytes from aged animals, including *Cxcl1, Lpar3,* and the secretable lipases *Pla2g2f* and *Pnliprp2.* Macrophage-derived lipases are known to induce foam cell formation \[[@R35]\]. CXCL1 is also involved in atherosclerosis \[[@R7]\], and LPAR3 is required for monocyte recruitment to atherosclerotic lesions by oxidized LDL \[[@R36]\].

The overexpression of inflammatory mediators, cytotoxic factors, and adhesion molecules in monocytes from aged rats fits two different but complementary theories of aging: the hyperfunction theory \[[@R37]\] and inflammaging \[[@R38]\]. In fact, the former theory explains the latter and postulates that increased functions in both immune and non-immune cells lead to a loss of homeostasis, chronic inflammation and age-related diseases.

The limitations of this study include the possibilities that cellular contaminants were introduced as part of our monocyte isolation procedures, and that the identified mRNA expression profiles do not correspond to protein levels as a result of post-translational regulation. In addition, it is conceivable that perivascular delivery of high numbers of monocytes using a Matrigel system might over-promote their migration into the wall, compared to physiological conditions. Despite these limitations, our study demonstrates that monocytes from aged rats, but not young animals, induce restenosis after arterial injury. Furthermore, we show that their gene expression profile not only explains this observed inflammatory and restenotic character, but also predicts a highly pro-atherogenic potential.

MATERIALS AND METHODS {#s4}
=====================

Isolation and purification of monocytes {#s4_1}
---------------------------------------

Aged Fischer (\>22-month-old, F344) rats were purchased from the National Institute of Aging (Bethesda, MD), while young (2-month-old) rats were obtained from Harlan Laboratories (Indianapolis, IN). Blood monocytes were isolated using density gradient followed by negative immunomagnetic separation \[[@R39]\]. Briefly, non-monocytic cells from Histopaque-1087 gradients were labeled with specific monoclonal antibodies (20 μg of Ox-8, Ox-19, Ox-33, Ox-52, anti-CD4, and anti-granulocytes from AbD Serotec) and discarded using anti-mouse magnetic beads. Monocytes purity was determined by FACS analysis using fluorescently labeled anti-CD4, -CD8, -CD11b, and -CD18 antibodies (AbD Serotec).

Balloon injury and perivascular cell delivery {#s4_2}
---------------------------------------------

The Institutional Committee for Use and Care of Laboratory Animals at the University of Miami previously approved all animal procedures. Balloon injury in the right iliac artery was inflicted with a 2F Fogarty catheter (Baxter Corp., Irvine, CA, USA) adapted to a custom angiographic kit (Boston Scientific, Scimed) \[[@R40]\]. Approximately 2×10^6^ monocytes from either aged or young rats were re-suspended in 0.2 ml of BD Matrigel™ Matrix (BD Biosciences, San Jose, CA) and seeded around iliac arteries prior to balloon injury. Control animals received a similar volume of Matrigel alone. Arterial specimens were collected 21 days after injury and fixed in 4% formalin-PBS (Sigma-Aldrich). The areas of the neointima and media layers were measured in H&E stained slides using the ImagePro software (Media Cybernetics, Bethesda, MD).

Immunohistochemistry {#s4_3}
--------------------

Paraffin sections were rehydrated and treated with 3% hydrogen peroxide to block endogenous peroxidase activity. Sections were boiled in citrate buffer to allow epitope retrieval. Non-specific binding sites were blocked with 0.5% blocking solution (DAKO, Carpinteria, CA) before adding primary antibodies against rat CD68 (AbD Serotec) and smooth muscle cell actin (DAKO) for 1 h at room temperature. Biotinylated secondary antibodies (DAKO Universal Link) were applied for 30 min, followed by a 15-min incubation with horseradish peroxidase-streptavidin solution (DAKO) at room temperature. Color was developed with a DAB chromogenic solution (DAKO). Nuclei were counterstained with Meyer\'s hematoxylin and mounted as described above.

Fresh isolated monocytes were cytospun onto microscope slides and fixed with cold methanol for 10 min at −20°C. Non-specific binding sites were blocked with 10% goat serum (Chemicon International, Temecula, CA) in PBS for 1 h at room temperature. Primary rabbit polyclonal antibodies against cadherin 13 and secreted frizzled-related protein 1 (Santa Cruz Biotechnology) were diluted in blocking solution and applied onto sections overnight at 4°C. After washing twice with PBS for 3 min, tissue sections were incubated with Alexa Fluor 488 (or 546) goat anti-rabbit (Invitrogen, Carlsbad, CA) for 90 min at room temperature. Sections were mounted in Vectashield w/DAPI (Vector Laboratories, Burlingame, CA) and examined with an Olympus BX 40 microscope (Olympus America Inc., Center Valley, PA).

RNA microarray analysis {#s4_4}
-----------------------

Total RNA from fresh isolated monocytes was extracted using TRI Reagent (Molecular Research Center, Cincinnati, OH), followed by an extra-cleaning step with the RNeasy kit (Qiagene, Valencia, CA). Gene expression profiling and data analyses were performed at Ocean Ridge Biosciences (Palm Beach Gardens, FL) using two-color Agilent Whole Rat Genome Arrays (Agilent Technologies). Differentially expressed genes were those with p-values and false discovery rates (FDR) under 0.05. Microarray results for selected genes were confirmed using TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA). Real-time PCR was performed on an ABI Prism 7500 Fast Real-Time PCR System and relative gene expression was determined using the ddCT method \[[@R41]\].

Statistical analyses {#s4_5}
--------------------

Results were expressed as means ± SE. Two-group comparisons were conducted using two-tailed t-tests for independent samples with unequal variances. Statistics were calculated with Prism 5 (GraphPad Software, La Jolla, CA).
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